TPX2 and prostate adenocarcinoma: The results showed that MKI67, TPX2, CDK1, CCNB2, UBE2C, CCNA2, CCNB1, BUB1B, CENPF, and RRM2 were overexpressed consistently in the Cancer Genome Atlas Prostate Adenocarcinoma samples.